Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

|Articles|April 15, 2016

Episode 2: How On-Dose Technologies Mitigate Safety Risks and Reduce Product Diversion and Counterfeiting

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

ByNicholas Jacobus

June 12th 2026

Stock.adobe.com Small cell lung cancer

Zepzelca Fails to Meet Main Goal of ‌Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer

ByNicholas Jacobus

June 12th 2026

Rick Winningham, CEO, Theravance

Rick Winningham: Building Leaders Behind the Pipeline

ByNicholas Jacobus

Published: June 12th 2026 | Updated: June 12th 2026

Stock.adobe.com

Kardigan Planning for $350 Million IPO Raise: Report

ByNicholas Jacobus

June 12th 2026

Lisa Bollinger

The Future for Disease Modifying Therapies for Lysosomal Disorders

ByMike Hollan,Lisa Bollinger

June 12th 2026

Trending on PharmExec

How New Technologies Are Impacting the Vaccine Market

The New Capital of Care in Rare Disease

Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

Kardigan Planning for $350 Million IPO Raise: Report

Zepzelca Fails to Meet Main Goal of ‌Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer